- Home
- CAPL vs MGTX Comparison
CAPL vs MGTX Comparison
Compare CAPL & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPL
- MGTX
- Stock Information
- Founded
- CAPL 1992
- MGTX 2015
- Country
- CAPL United States
- MGTX United States
- Employees
- CAPL N/A
- MGTX N/A
- Industry
- CAPL Oil Refining/Marketing
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAPL Energy
- MGTX Health Care
- Exchange
- CAPL Nasdaq
- MGTX Nasdaq
- Market Cap
- CAPL 800.9M
- MGTX 670.2M
- IPO Year
- CAPL 2012
- MGTX N/A
- Fundamental
- Price
- CAPL $21.10
- MGTX $8.74
- Analyst Decision
- CAPL
- MGTX Strong Buy
- Analyst Count
- CAPL 0
- MGTX 3
- Target Price
- CAPL N/A
- MGTX $25.67
- AVG Volume (30 Days)
- CAPL 29.7K
- MGTX 431.9K
- Earning Date
- CAPL 11-05-2025
- MGTX 11-12-2025
- Dividend Yield
- CAPL 9.95%
- MGTX N/A
- EPS Growth
- CAPL 100.77
- MGTX N/A
- EPS
- CAPL 1.13
- MGTX N/A
- Revenue
- CAPL $3,522,840,000.00
- MGTX $37,917,000.00
- Revenue This Year
- CAPL N/A
- MGTX $144.79
- Revenue Next Year
- CAPL N/A
- MGTX $168.58
- P/E Ratio
- CAPL $18.73
- MGTX N/A
- Revenue Growth
- CAPL N/A
- MGTX 366.84
- 52 Week Low
- CAPL $19.50
- MGTX $4.55
- 52 Week High
- CAPL $25.73
- MGTX $9.44
- Technical
- Relative Strength Index (RSI)
- CAPL 62.60
- MGTX 57.84
- Support Level
- CAPL $19.67
- MGTX $8.42
- Resistance Level
- CAPL $20.37
- MGTX $9.44
- Average True Range (ATR)
- CAPL 0.41
- MGTX 0.62
- MACD
- CAPL 0.11
- MGTX 0.06
- Stochastic Oscillator
- CAPL 96.69
- MGTX 65.99
About CAPL CrossAmerica Partners LP Common Units representing limited partner interests
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.